Overall, our study shows that TMCO3, a highly expressed and high m6A‐modification level molecule in HCC, is involved in the regulation of AKT through the PI3K/AKT pathway and ultimately promotes the progression of HCC (Figure 8J). The gene discussed is SLC9D1; the disease is hepatocellular carcinoma.